GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » Current Accrued Expense

Pet Pharm Biotech Co (ROCO:7762) Current Accrued Expense : NT$0.0 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co Current Accrued Expense?

Pet Pharm Biotech Co's Current Accrued Expense for the quarter that ended in Jun. 2024 was NT$0.0 Mil.


Pet Pharm Biotech Co Current Accrued Expense Historical Data

The historical data trend for Pet Pharm Biotech Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co Current Accrued Expense Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23
Current Accrued Expense
- -

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
Current Accrued Expense - - - -

Pet Pharm Biotech Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Pet Pharm Biotech Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Pet Pharm Biotech Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines